A recent study investigates whether apixaban is superior to aspirin in preventing nonlacunar covert infarcts in patients with ...
Further trials comparing aspirin with newer anticoagulants ... Based on the ARISTOTLE study, apixaban demonstrated a greater overall reduction in the rate of stroke and a lower rate of bleeding ...
Based on the ARISTOTLE study, apixaban demonstrated a greater ... Based on the AVEROSS trial, apixaban was superior to aspirin in patients unsuitable for warfarin in stroke prevention in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results